Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Somatomedin.

J D Bomboy, W D Salmon

    Clinical Orthopaedics and Related Research
    |May 11, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Somatomedin, a growth hormone mediator, impacts cartilage and has insulin-like effects. Its levels indicate various conditions, including growth hormone deficiency and acromegaly.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Stimulation of sulfate and thymidine incorporation into hypophysectomized rat cartilage by growth hormone and insulin-like growth factor-I in vitro: the somatomedin hypothesis revisited.

    The Journal of laboratory and clinical medicine·1997
    Same author

    Intraocular tumor from disseminated histoplasmosis.

    Southern medical journal·1991
    Same author

    Hypercalcemia in active pulmonary tuberculosis.

    Southern medical journal·1987
    Same author

    Hypercortisolism, diarrhea with steatorrhea, and massive proteinuria due to pheochromocytoma.

    Southern medical journal·1985
    Same author

    Stimulation of uridine, leucine, and sulfate incorporation into rat cartilage macromolecules by adenosine 3',5'-monophosphate.

    Endocrinology·1984
    Same author

    Effects of endotoxemia on cyclic nucleotides in the unanesthetized sheep.

    The Journal of laboratory and clinical medicine·1983
    Same journal

    Impact Microindentation Evaluates Bone Strength, Bone Quality, and Fracture Susceptibility Across Skeletal Sites: A Cadaver Study.

    Clinical orthopaedics and related research·2026
    Same journal

    What Is the Effect of Robot Reduction in Displaced Pelvic Fractures? A Multicenter Randomized Clinical Trial.

    Clinical orthopaedics and related research·2026
    Same journal

    Radial Head Fractures Cluster in the Anterolateral and Anteromedial Quadrants and Do Not Correlate With Coronoid Fracture Types.

    Clinical orthopaedics and related research·2026
    Same journal

    Reduced Cerebellar Activation With Eyes Closed Is Associated With Delayed Peroneal Reaction Time in Patients With Chronic Ankle Instability.

    Clinical orthopaedics and related research·2026
    Same journal

    Are Social Determinants of Health Disparities Associated With Worse Completion Rates for Patient-reported Outcome Measures After Total Joint Arthroplasty?

    Clinical orthopaedics and related research·2026
    Same journal

    Are Age-based Cutoffs for THA Logically Consistent?

    Clinical orthopaedics and related research·2026
    See all related articles

    Area of Science:

    • Endocrinology
    • Biochemistry
    • Molecular Biology

    Background:

    • Somatomedin is a serum peptide believed to mediate growth hormone's effects on skeletal tissue.
    • It stimulates synthesis of mucopolysaccharides, proteins, and nucleic acids in cartilage.
    • Insulin-like effects on non-skeletal tissues suggest links to NSILA-S and MSA.

    Purpose of the Study:

    • To elucidate the role of somatomedin in growth and its relationship with growth hormone.
    • To investigate factors influencing somatomedin levels.
    • To understand the diagnostic significance of somatomedin in endocrine disorders.

    Main Methods:

    • Bioassays were used to measure somatomedin levels.
    • Correlation between somatomedin and growth hormone was assessed.

    Related Experiment Videos

  • Clinical data from patients with various endocrine conditions were analyzed.

    • Main Results:

    • Decreased somatomedin is associated with growth hormone deficiency, malnutrition, corticosteroid/estrogen therapy, and specific dwarfism.
    • Normal somatomedin with low growth hormone observed in hypothalamic tumors.
    • Somatomedin levels are elevated in acromegaly.

    Conclusions:

    • Somatomedin plays a crucial role in growth hormone action, particularly on skeletal tissue.
    • Somatomedin levels serve as a valuable indicator in diagnosing and monitoring endocrine disorders.
    • Further research is needed to address the non-specificity of bioassays and unexplained clinical observations.